title: What is the role for antithrombotics in cancer care? Interactive session with panel discussion.
authors.affiliation: Imperial College, London, UK. akkakkar@tri-london.ac.uk
authors.forename: Ajay K
authors.initials: AK
authors.lastname: Kakkar
authors.forename: Mark N
authors.initials: MN
authors.lastname: Levine
authors.forename: Paolo
authors.initials: P
authors.lastname: Prandoni
authors.forename: Agnes Y
authors.initials: AY
authors.lastname: Lee
authors.forename: Morten S
authors.initials: MS
authors.lastname: Rasmussen
authors.forename: David
authors.initials: D
authors.lastname: Kuter
mesh_terms: D003657:Decision Making; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D055502:Secondary Prevention; D020246:Venous Thrombosis / Q000150:complications / Q000628:therapy*
chemical_list: D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight